Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety

Clinical trial NCT00944268 · UNKNOWN

Trial details

NCT number: NCT00944268
Sponsor: Ativus Farmaceutica Ltda
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Anxiety Efficacy Tolerability

Start date: 2009-09-01
Primary completion: 2009-12-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.